| 9.99 -0.37 (-3.57%) | 11-04 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 13.19 | 1-year : | 15.41 |
| Resists | First : | 11.3 | Second : | 13.19 |
| Pivot price | 10.18  |
|||
| Supports | First : | 8.96 | Second : | 7.51 |
| MAs | MA(5) : | 10.39 |
MA(20) : | 9.91 |
| MA(100) : | 7.85 |
MA(250) : | 10.17 |
|
| MACD | MACD : | 0.5 |
Signal : | 0.6 |
| %K %D | K(14,3) : | 55.2 |
D(3) : | 67.4 |
| RSI | RSI(14): 56.9 |
|||
| 52-week | High : | 18.54 | Low : | 4.29 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ CVRX ] has closed above bottom band by 36.6%. Bollinger Bands are 20.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 11.31 - 11.36 | 11.36 - 11.42 |
| Low: | 10.12 - 10.17 | 10.17 - 10.23 |
| Close: | 10.27 - 10.36 | 10.36 - 10.44 |
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Tue, 04 Nov 2025
Earnings To Watch: CVRx Inc (CVRX) Reports Q3 2025 Result - Yahoo Finance
Tue, 04 Nov 2025
CVRx to Present at the Jefferies Global Healthcare Conference in London - GlobeNewswire
Tue, 04 Nov 2025
Can CVRx Inc. recover in the next quarter - Quarterly Market Summary & Consistent Growth Stock Picks - newser.com
Mon, 03 Nov 2025
CVRx Inc expected to post a loss of 50 cents a share - Earnings Preview - TradingView
Mon, 03 Nov 2025
$CVRX stock is up 7% today. Here's what we see in our data. - Quiver Quantitative
Mon, 03 Nov 2025
Detecting support and resistance levels for CVRx Inc. - Market Sentiment Report & Free Technical Confirmation Trade Alerts - newser.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 26 (M) |
| Shares Float | 18 (M) |
| Held by Insiders | 4.3 (%) |
| Held by Institutions | 67.6 (%) |
| Shares Short | 1,800 (K) |
| Shares Short P.Month | 1,870 (K) |
| EPS | -2.06 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.22 |
| Profit Margin | -95.7 % |
| Operating Margin | -105.8 % |
| Return on Assets (ttm) | -29.7 % |
| Return on Equity (ttm) | -92.4 % |
| Qtrly Rev. Growth | 15.1 % |
| Gross Profit (p.s.) | 1.75 |
| Sales Per Share | 2.09 |
| EBITDA (p.s.) | -1.94 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -39 (M) |
| Levered Free Cash Flow | -23 (M) |
| PE Ratio | -4.85 |
| PEG Ratio | 0 |
| Price to Book value | 4.5 |
| Price to Sales | 4.76 |
| Price to Cash Flow | -6.66 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|